October 03, 2017
Integra LifeSciences Holdings Corporation (IART – Free Report) has finally come up with the news of completing Codman Neurosurgery business acquisition from Johnson & Johnson (JNJ – Free Report) . This development was expected at the heels of last month’s major asset divestment initiative by the company. The whopping $1.045 billion purchase has been considered a major breakthrough for Integra as it will provide the company with global reach in Neurosurgery, thus connoting the core expertise within the company’s Specialty Surgical Solutions.